HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BLUEBIRD BIO, INC.
455 Grand Union Boulevard, Somerville, MA, 02145, US
CHRISTINA HARTMAN